Research programme: hydroxysteroid dehydrogenase inhibitors - Bioenvision
Latest Information Update: 16 Mar 2007
At a glance
- Originator Unknown
- Class
- Mechanism of Action Hydroxysteroid dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 28 Oct 2003 Preclinical trials in Prostate cancer in United Kingdom (unspecified route)